These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16680932)

  • 21. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
    Enomoto T; Lu HQ; Yin M; Sakoda T; Dake Y; Enomoto K; Ide T; Cheng L
    J Investig Allergol Clin Immunol; 2009; 19(4):299-305. PubMed ID: 19639726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fexofenadine reduces nasal congestion in perennial allergic rhinitis.
    Ciprandi G; Cosentino C; Milanese M; Mondino C; Canonica GW
    Allergy; 2001 Nov; 56(11):1068-70. PubMed ID: 11703220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF; Corren J; Wheeler WJ; Berger WE;
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis.
    Berkowitz RB; Braker S; Lutz C; Jones P; Meeves S; Qiu C; Varghese ST; Georges G
    Ann Allergy Asthma Immunol; 2006 Feb; 96(2):327-33. PubMed ID: 16498855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
    Simpson K; Jarvis B
    Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
    Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
    Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of seasonal increase in serum interleukin-5 is linked to the clinical efficacy of immunotherapy for seasonal allergic rhinitis.
    Hayashi M; Ohashi Y; Tanaka A; Kakinoki Y; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():133-42. PubMed ID: 9879413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
    Bernstein DI; Schoenwetter WF; Nathan RA; Storms W; Ahlbrandt R; Mason J
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
    Hampel F; Ratner P; Mansfield L; Meeves S; Liao Y; Georges G
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):354-61. PubMed ID: 14582814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized control trail of stepwise treatment with fluticasone propionate nasal spray and fexofenadine hydrochloride tablet for seasonal allergic rhinitis.
    Takahashi G; Matsuzaki Z; Okamoto A; Ito E; Matsuoka T; Nakayama T; Masuyama K
    Allergol Int; 2012 Mar; 61(1):155-62. PubMed ID: 22189593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
    Van Cauwenberge P; Juniper EF
    Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of fexofenadine on T-cell function in a murine model of allergen-induced airway inflammation and hyperresponsiveness.
    Gelfand EW; Cui ZH; Takeda K; Kanehiro A; Joetham A
    J Allergy Clin Immunol; 2003 Oct; 112(4 Suppl):S89-95. PubMed ID: 14530794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
    Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
    J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
    Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
    Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines.
    Bensch GW; Nelson HS; Borish LC
    Ann Allergy Asthma Immunol; 2002 May; 88(5):457-62. PubMed ID: 12027065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
    Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pranlukast hydrate on airway hyperresponsiveness in non-asthmatic patients with Japanese cedar pollinosis.
    Sagara H; Yukawa T; Kashima R; Okada T; Fukuda T
    Allergol Int; 2009 Jun; 58(2):277-87. PubMed ID: 19390239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of specific immunotherapy versus loratadine on serum adhesion molecules.
    Ferreira MB; Santos MC; Pregal AL; Alonso E; Santos AS; Palma-Carlos ML; Palma-Carlos AG
    Allerg Immunol (Paris); 2001 Oct; 33(8):319-22. PubMed ID: 11763722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
    Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
    Allergy Asthma Proc; 2004; 25(5):335-43. PubMed ID: 15603207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.